Arcus Biosciences, Inc. (RCUS)
29.21
-1.38
(-4.51%)
USD |
NYSE |
Aug 28, 16:00
29.18
-0.03
(-0.10%)
After-Hours: 20:00
Arcus Biosciences Debt to Equity Ratio : 0.2457 for June 30, 2026
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.2457 |
| March 31, 2026 | 0.2156 |
| December 31, 2025 | 0.3138 |
| September 30, 2025 | 0.2546 |
| June 30, 2025 | 0.1985 |
| March 31, 2025 | 0.113 |
| December 31, 2024 | 0.3278 |
| September 30, 2024 | 0.1027 |
| June 30, 2024 | 0.0173 |
| March 31, 2024 | 0.0156 |
| December 31, 2023 | 0.2619 |
| September 30, 2023 | 0.0173 |
| June 30, 2023 | 0.00 |
| March 31, 2023 | 0.00 |
| December 31, 2022 | 0.1826 |
| September 30, 2022 | 0.1706 |
| June 30, 2022 | 0.1624 |
| March 31, 2022 | 0.1441 |
| Date | Value |
|---|---|
| December 31, 2021 | 0.145 |
| September 30, 2021 | 0.0902 |
| June 30, 2021 | 0.0823 |
| March 31, 2021 | 0.0221 |
| December 31, 2020 | 0.0361 |
| September 30, 2020 | 0.00 |
| June 30, 2020 | 0.00 |
| March 31, 2020 | 0.00 |
| December 31, 2019 | 0.00 |
| September 30, 2019 | 0.00 |
| June 30, 2019 | 0.00 |
| March 31, 2019 | 0.00 |
| December 31, 2018 | 0.00 |
| September 30, 2018 | 0.00 |
| June 30, 2018 | 0.00 |
| March 31, 2018 | 0.00 |
| December 31, 2017 | 0.00 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| Halozyme Therapeutics, Inc. | 14.95 |
| AVITA Medical, Inc. | -1.742 |
| Iovance Biotherapeutics, Inc. | 0.0625 |
| Editas Medicine, Inc. | 0.6768 |
| Recursion Pharmaceuticals, Inc. | 0.0728 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 924.00M |
| Total Liabilities (Quarterly) | 460.00M |
| Shareholders Equity (Quarterly) | 464.00M |
| Current Ratio | 3.818 |
| Net Debt Paydown Yield | -0.28% |